Clinical Trial: Ocular Penetration of Topical Tacrolimus Eye Drops

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title:

Brief Summary:

Investigators aim to evaluate the ocular penetration of topical tacrolimus 0.03% eye drops.

Topical tacrolimus 0.03% will be instilled into the eyes of patients 15 minutes before cataract surgery. Aqueous samples will be collected at the time of cataract surgery and will be subjected to detection of presence and level of tacrolimus.

Detailed Summary:
Sponsor: The Eye Center and The Eye Foundation for Research in Ophthalmology

Current Primary Outcome: Detection of the concentration of tacrolimus ( nanograms/milliliter) in the anterior chamber following ocular topical application. [ Time Frame: From date of obtaining the aqueous samples until getting the laboratory results of concentration of topical tacrolimus in the aqueous humor up to 2 months ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: The Eye Center and The Eye Foundation for Research in Ophthalmology

Dates:
Date Received: May 26, 2016
Date Started: May 2016
Date Completion: July 2016
Last Updated: June 8, 2016
Last Verified: May 2016